866862-25-1 Usage
Uses
Used in Pharmaceutical Industry:
1H-INDEN-1-ONE, 5-BROMO-6-FLUORO-2,3-DIHYDROis used as a chemical intermediate for the synthesis of pharmaceutical compounds due to its unique structure and the presence of bromine and fluorine atoms, which can influence the compound's reactivity and biological activity.
Used in Agrochemical Industry:
1H-INDEN-1-ONE, 5-BROMO-6-FLUORO-2,3-DIHYDROmay be utilized as a precursor in the development of agrochemicals, where its specific chemical properties could contribute to the creation of novel pesticides or herbicides.
Used in Materials Science:
1H-INDEN-1-ONE, 5-BROMO-6-FLUORO-2,3-DIHYDROcould be employed in the field of materials science for the design of new materials with tailored properties, such as improved thermal stability or specific optical characteristics,得益于其独特的化学结构和原子组成.
(Note: The original instruction was to list the uses of Glycerol, but the provided materials were about 1H-INDEN-1-ONE, 5-BROMO-6-FLUORO-2,3-DIHYDRO-. Therefore, the uses listed are for the latter compound based on the information provided.)
Check Digit Verification of cas no
The CAS Registry Mumber 866862-25-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,8,6 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 866862-25:
(8*8)+(7*6)+(6*6)+(5*8)+(4*6)+(3*2)+(2*2)+(1*5)=221
221 % 10 = 1
So 866862-25-1 is a valid CAS Registry Number.
866862-25-1Relevant academic research and scientific papers
HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF
-
Paragraph 0415; 0417, (2021/02/25)
The present invention relates to a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the treatment of various HAT-related diseases or conditions.
AMINO-PYRIDINE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS
-
Paragraph 00181, (2014/05/24)
The invention provides certain amino-pyridine-containing compounds of the Formula (I) (I) or pharmaceutically acceptable salts thereof, wherein R3, R4, R5, R6, and the subscript n are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.
